Trials / Completed
CompletedNCT03040206
Risk Stratification of Nodal PTCL
Multicenter Study to Assess the Prognostic Significances of NCCN-IPI and Post-treatment PET Results in Patients With Newly Diagnosed Nodal PTCL
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 405 (actual)
- Sponsor
- Chonbuk National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This study is to investigate the prognostic significance of enhanced International Prognostic Index (NCCN-IPI) and post-treatment PET results in patients with newly diagnosed nodal peripheral T-cell lymphoma (PTCL), and establish a risk stratification model for nodal PTCL patients.
Conditions
- Peripheral T-Cell Lymphoma, Not Otherwise Specified
- Angioimmunoblastic T-cell Lymphoma
- Anaplastic Large Cell Lymphoma, ALK-negative
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2017-06-01
- Completion
- 2017-12-01
- First posted
- 2017-02-02
- Last updated
- 2019-08-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03040206. Inclusion in this directory is not an endorsement.